SCHEMBL30480903

SCHEMBL30480903

Cc1cc2c(OS(=O)(=O)C(F)(F)F)cc(N3CCOCC3)cc2n(C)c1=O

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PIK3CA P42336 4/20 0.34
BRD4 O60885 2/20 0.34
AKT1 P31749 3/20 0.34
MTOR P42345 3/20 0.34
PDE2A O00408 2/20 0.34
PDE10A Q9Y233 2/20 0.34
POLB P06746 2/20 0.34
BRPF1 P55201 1/20 0.34
MAPT P10636 2/20 0.33
TP53 P04637 1/20 0.33
CCL2 P13500 1/20 0.33
BAZ2A Q9UIF9 1/20 0.33
REV1 Q9UBZ9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26547751 1.00 KDM4E (0.34) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL26547757 0.85 DRD2 (0.33) KDM4EALDH1A1GAAHSD17B10BRPF1
SCHEMBL26547744 0.82 PIK3CA (0.45) KDM4EALDH1A1HPGDPIK3CABRD4
SCHEMBL30480887 0.82 PIK3CA (0.45) KDM4EALDH1A1HPGDPIK3CABRD4
SCHEMBL31496104 0.81 PIK3CA (0.40) ALDH1A1PIK3CAMAPT
SCHEMBL26547775 0.81 DRD2 (0.40) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL29471189 0.81 DRD2 (0.40) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL31425941 0.81 KDM4E (0.31) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL26547777 0.78 DRD2 (0.39) BRD4BRPF1BAZ2A
SCHEMBL31248926 0.78 BRPF1 (0.33) BRD4BRPF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720057-A2 COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF Oncopia Therapeutics, Inc. D/B/A SK Life Science Labs (US) 2026-04-08 EP disclosed
WO-2024249888-A2 COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF ONCOPIA THERAPEUTICS, INC. D/B/A SK LIFE SCIENCE LABS (US) 2024-12-05 WO disclosed
CN-116368128-A Heterocyclic compounds as CBP/EP300 bromodomain inhibitors 奥瑞基尼肿瘤有限公司 2023-06-30 CN disclosed